dual glp-1/glucagon receptor agonists Effects, working principles and target tissues of GLP-1 Receptor Agonists Explained for

Learn more about the differences to see which is best for you

Antiamyloid therapies have recently changed the treatment landscape

Covers SURPASS/SURMOUNT trials, dosing, and semaglutide comparison.

The medication, sold under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor agonists are a ...

Ahead of the Trump administrations planned expansion of Medicare coverage for GLP-1s to treat obesity through temporary models and the availability of Medicares negotiated price for certain GLP-1 products beginning in 2027, this analysis examines CMSs Medicare Part D claims data from 2019 to 2024 to document the increase in the number of beneficiaries being treated with GLP-1 drugs and the growth in Medicare spending and claims for these drugs.